Skip to main content
Premium Trial:

Request an Annual Quote

Italy s Bouty to Distribute Cortex Biochem s Nucleic Acid Isolation Kits

NEW YORK, June 14 (GenomeWeb News) - Cortex Biochem, a provider of magnetic particle-based reagents, said today that Bouty of Milan, Italy, will exclusively market its MagaZorb nucleic acid isolation kits and associated reagents in Italy.

 

The agreement is effective as of January, and allows Bouty and Bouty's Technogenetics biotech subsidiary to distribute the products.

 

"We are confident that this is the ideal partnership to firmly establish our technology in the European market," said Matt Pourfarzaneh, president and CEO of Cortex, in a statement.

The Scan

And Back

The New York Times reports that missing SARS-CoV-2 genome sequences are back in a different database.

Lacks Family Hires Attorney

A lawyer for the family of Henrietta Lacks plans to seek compensation from pharmaceutical companies that have used her cancer cells in product development, the Baltimore Sun reports.

For the Unknown

The Associated Press reports that family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who were on the USS Arizona.

PLOS Papers on Congenital Heart Disease, COVID-19 Infection Host MicroRNAs, Multiple Malformation Mutations

In PLOS this week: new genes linked to congenital heart disease, microRNAs with altered expression in COVID-19, and more.